Research ArticleArticle
Soluble LILRA3, a Potential Natural Antiinflammatory Protein, Is Increased in Patients with Rheumatoid Arthritis and Is Tightly Regulated by Interleukin 10, Tumor Necrosis Factor-α, and Interferon-γ
Hongyan An, Vasudha Chandra, Barbara Piraino, Luis Borges, Carolyn Geczy, H. Patrick McNeil, Katherine Bryant and Nicodemus Tedla
The Journal of Rheumatology July 2010, jrheum.091119; DOI: https://doi.org/10.3899/jrheum.091119
Hongyan An
Vasudha Chandra
Barbara Piraino
Luis Borges
Carolyn Geczy
H. Patrick McNeil
Katherine Bryant
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Soluble LILRA3, a Potential Natural Antiinflammatory Protein, Is Increased in Patients with Rheumatoid Arthritis and Is Tightly Regulated by Interleukin 10, Tumor Necrosis Factor-α, and Interferon-γ
Hongyan An, Vasudha Chandra, Barbara Piraino, Luis Borges, Carolyn Geczy, H. Patrick McNeil, Katherine Bryant, Nicodemus Tedla
The Journal of Rheumatology Jul 2010, jrheum.091119; DOI: 10.3899/jrheum.091119
Soluble LILRA3, a Potential Natural Antiinflammatory Protein, Is Increased in Patients with Rheumatoid Arthritis and Is Tightly Regulated by Interleukin 10, Tumor Necrosis Factor-α, and Interferon-γ
Hongyan An, Vasudha Chandra, Barbara Piraino, Luis Borges, Carolyn Geczy, H. Patrick McNeil, Katherine Bryant, Nicodemus Tedla
The Journal of Rheumatology Jul 2010, jrheum.091119; DOI: 10.3899/jrheum.091119